Role of CYP2C19 pharmacogenetic polymorphism on response of esomeprazole in the treatment of GERD

被引：0
作者：
Halimi, Shafarul
Abu Hassan, Muhammad Radzi
Ismail, Rusli
Kiew, Kuang Kiat
Zainuddin, Zalwani
Mustapha, Mohd Nazri
Mokhtar, Suraya
机构：
[1] Univ Sains Malaysia, George Town, Malaysia
[2] Hosp Univ Sains Malaysia, George Town, Malaysia
来源：
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY | 2013年 / 28卷
关键词：
pharmacogenetics; polymorphism; GERD;
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：67 / 68
页数：2
相关论文
共 50 条
  • [21] Functional characterization of two novel CYP2C19 variants (CYP2C19*18 and CYP2C19*19) found in a Japanese population
    Hanioka, N.
    Tsuneto, Y.
    Saito, Y.
    Sumada, T.
    Maekawa, K.
    Saito, K.
    Sawada, J.
    Narimatsu, S.
    XENOBIOTICA, 2007, 37 (04) : 342 - 355
  • [22] Pharmacogenetic variation at CYP2C9, CYP2C19, and CYP2D6 at global and microgeographic scales
    Sistonen, Johanna
    Fuselli, Silvia
    Palo, Jukka U.
    Chauhan, Neelam
    Padh, Harish
    Sajantila, Antti
    PHARMACOGENETICS AND GENOMICS, 2009, 19 (02) : 170 - 179
  • [23] Feasibility of pharmacy-initiated pharmacogenetic screening for CYP2D6 and CYP2C19
    Swen, J. J.
    van der Straaten, T.
    Wessels, J. A. M.
    Bouvy, M. L.
    Vlassak, E. E. W.
    Assendelft, W. J. J.
    Guchelaar, H. -J.
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2012, 68 (04) : 363 - 370
  • [24] Feasibility of pharmacy-initiated pharmacogenetic screening for CYP2D6 and CYP2C19
    J. J. Swen
    T. van der Straaten
    J. A. M. Wessels
    M. L. Bouvy
    E. E. W. Vlassak
    W. J. J. Assendelft
    H.-J. Guchelaar
    European Journal of Clinical Pharmacology, 2012, 68 : 363 - 370
  • [25] Role of CYP2C19 polymorphisms in patients with endometriosis
    Cayan, Filiz
    Ayaz, Lokman
    Aban, Meral
    Dilek, Saffet
    Guemues, Lueluefer Tamer
    GYNECOLOGICAL ENDOCRINOLOGY, 2009, 25 (08) : 530 - 535
  • [26] Role of CYP2C9, CYP2C19 and EPHX Polymorphism in the Pharmacokinetic of Phenytoin: A Study on Uruguayan Caucasian Subjects
    Guevara, Natalia
    Maldonado, Cecilia
    Uria, Manuel
    Gonzalez, Raquel
    Ibarra, Manuel
    Alvariza, Silvana
    Carozzi, Antonella
    Azambuja, Carlos
    Fagiolino, Pietro
    Vazquez, Marta
    PHARMACEUTICALS, 2017, 10 (03)
  • [27] Inhibitory effect of oral contraceptives on CYP2C19 activity is not significant in carriers of the CYP2C19*17 allele
    Pedersen, Rasmus S.
    Noehr-Jensen, Lene
    Brosen, Kim
    CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 2013, 40 (10): : 683 - 688
  • [28] Pharmacogenetic associations of CYP2C19 genotype with in vivo metabolisms and pharmacological effects of thalidomide
    Ando, L
    Price, DK
    Dahut, WL
    Cox, MC
    Reed, E
    Figg, WD
    CANCER BIOLOGY & THERAPY, 2002, 1 (06) : 669 - 673
  • [29] The significance of pharmacogenetic CYP2C19 testing for personalization of the antiplatelet therapy in cardiology practice
    Mirzaev, K. B.
    Sychev, D. A.
    Andreev, D. A.
    Prokofiev, A. B.
    RATIONAL PHARMACOTHERAPY IN CARDIOLOGY, 2013, 9 (04) : 404 - 408
  • [30] CYP2C19*17 genetic polymorphism-an uncommon cause of voriconazole treatment failure
    Abidi, Maheen Z.
    D'Souza, Anita
    Kuppalli, Krutika
    Ledeboer, Nathan
    Hari, Parmeswaran
    DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2015, 83 (01) : 46 - 48
12345